1. Home
  2. SPPL vs INTS Comparison

SPPL vs INTS Comparison

Compare SPPL & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPPL
  • INTS
  • Stock Information
  • Founded
  • SPPL 2016
  • INTS 2012
  • Country
  • SPPL Singapore
  • INTS United States
  • Employees
  • SPPL N/A
  • INTS N/A
  • Industry
  • SPPL
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPPL
  • INTS Health Care
  • Exchange
  • SPPL Nasdaq
  • INTS Nasdaq
  • Market Cap
  • SPPL 9.8M
  • INTS 8.4M
  • IPO Year
  • SPPL 2023
  • INTS 2023
  • Fundamental
  • Price
  • SPPL $3.11
  • INTS $0.28
  • Analyst Decision
  • SPPL
  • INTS Strong Buy
  • Analyst Count
  • SPPL 0
  • INTS 4
  • Target Price
  • SPPL N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • SPPL 17.5K
  • INTS 3.8M
  • Earning Date
  • SPPL 01-01-0001
  • INTS 08-07-2025
  • Dividend Yield
  • SPPL N/A
  • INTS N/A
  • EPS Growth
  • SPPL N/A
  • INTS N/A
  • EPS
  • SPPL N/A
  • INTS N/A
  • Revenue
  • SPPL $2,764,846.00
  • INTS N/A
  • Revenue This Year
  • SPPL N/A
  • INTS N/A
  • Revenue Next Year
  • SPPL N/A
  • INTS N/A
  • P/E Ratio
  • SPPL N/A
  • INTS N/A
  • Revenue Growth
  • SPPL N/A
  • INTS N/A
  • 52 Week Low
  • SPPL $2.16
  • INTS $0.19
  • 52 Week High
  • SPPL $16.80
  • INTS $4.34
  • Technical
  • Relative Strength Index (RSI)
  • SPPL 50.26
  • INTS 45.18
  • Support Level
  • SPPL $2.97
  • INTS $0.27
  • Resistance Level
  • SPPL $3.20
  • INTS $0.32
  • Average True Range (ATR)
  • SPPL 0.18
  • INTS 0.02
  • MACD
  • SPPL -0.00
  • INTS -0.00
  • Stochastic Oscillator
  • SPPL 33.45
  • INTS 29.48

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: